Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


Review is devoted to the value of the use of highly sensitive troponin (hs-cTn) tests in the diagnosis of acute coronary syndrome. The classification of the Tn-tests depending on their sensitivity is presented. The possible reasons of troponins appearance in blood of healthy people are shown. Authors consider a 3-hour algorithm for myocardial infarction (MI) diagnostic, recommended by the expert group in 2012. Study results of 2011-2015 years are presented as the basis for the development of a one-hour MI diagnostic algorithm, recommended by the European Society of Cardiology in 2015. Authors discuss the results of studies showing that modern HS-cTnt tests (together with ECG assessment) are capable to diagnose MI in the early stages. They significantly increase the number of identified MI, especially MI without ST segment elevation, as well as identify the group of patients with subsequent favorable prognosis.

About the Authors

L. V. Kremneva
Tyumen State Medical University, Tyumen
Russian Federation

S. N. Suplotov
Tyumen State Medical University, Tyumen
Russian Federation

S. V. Shalaev
Tyumen State Medical University, Tyumen
Russian Federation


1. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21: 1502-13.

2. Thygesen K., Alpert J.S., White H.D. on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction. Eur Heart J 2007;28:2525.

3. IFCC. Analytical characteristics of commercial and research cardiac troponin I and T assays declared by the manufacturer. Available at: Checked by 23.03.2016.

4. Giannitsis E., Kurz K., Hallermayer K. et al. Analytical validation of high-sensitivity cardiac troponin Tassay. Clin Chem 2010;56:254-61.

5. Apple F.S., Collinson P.O., IFCC Task Force on Clinical Application of Cardiac Biomarkers. Analytical Characteristics of high sensitivity cardiac troponin assays. Clin Chem 2011;58;54-61.

6. Lippi G., Montagnana M., Aloe R., Cervellin G. High sensitive troponin immunoassays: navigating between the Scylla and charybdis. Adv Clin Chem 2012;58:1-29.

7. de Lemos J.A., Increasingly sensitive Assay for Cardiac Troponins. JAMA 2013;309(21):2262-9.

8. Apple F.S. A new season for cardiac troponin assay: its time to keep a scorerard. Clin Chem 2009;55:1303-6.

9. Jaffe A.S., Wu A.H.B. Troponin Release-Reversible or Irreversible Injury ? Should We Care? Clinical Chemistry 2012;58:1148-50.

10. Labugger R., Organ L., Collier C. et al. Extensive troponin I and T modification detected in serum from patients with acute myocardial Infarction. Circulation 2000;102(11):1221-6.

11. Apple F.S., Standartization of Cardiac Troponin I Assays Will Not Occur in Lifetime. Clin Chem 2012;58:169-71.

12. Thygesen K., Alpert J.S., Jaffe A.S. et al. Third Universal Definition of Myocardial Infarction. Circulation 2012;126(16):2020-35.

13. Costa F.M., Ferreira J., Aguiar C. et al. Impact of ESC/ACC/AHA/WHF universal definition of myocardial infarction on mortality at 10 years. Eur Heart J 2012;33(20):2544-50.

14. Mills N.L., Churchhouse A.M., Lee K.K. et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 2011;305(12):1210-6.

15. Mills N.L., Lee K.K., McAllister D.A. et al. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMI 2012;344:1533-44.

16. Korosoglou G., Lehrke S., Mueller D. et al. Determinants of troponin release in patients with stable coronary artery disease: Insights from CT angiography characteristics of atherosclerotic plaque. Heart 2011;97:823-31.

17. Rubin J., Matsushita K., Ballantyne C.M. et al. Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol 2012;59(5):484-9.

18. Pascual-Figal D.A., Casas T., Ordonez-Lianes J. et al. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. Am Heart J 2012; 163(6);1002-10.

19. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Suppl 2013;3:1-150.

20. Masson S., Latini R., Mureddu G.F. et al. High-sensitivity cardiac troponin T for detection on subtle abnormalities of cardiac phenotype in a general population of elderly individuals. J Intern Med 2013; 273(3):306-17.

21. Thygesen K., Mair I., Giannitsis E. et al. How to Use High-Sensitivity Cardiac Troponins in Acute Cardiac Care. Eur Heart J 2012;33(18):2252-7.

22. Body R., Carley S., Mcdowell G. et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011;58(13):1332-9.

23. Kelly A.M., Klim Sh. Does undetectable troponin J at presentation using a contemporary sensitive assay rule out myocardial infarction? A cohort study. Emerg Med J 2014;32:760-3.

24. Carlton E.W., Cullen L., Than M. et al. A novel diagnostic protocol to identify patients suitable for discharge after a single high-sensitivity troponin. Heart 2015;101(13):1041-6.

25. Bandstein N., Ljung R., Johamsson M., Holzmann M.J. et al. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. JACC 2014;63:2569-78.

26. Thelin J., Melander O., Ohlin B. Early rule-out of acute coronary syndrome using undetectable levels of high sensitivity troponin T. Eur Heart J Acute Cardiovasc Care 2014;4(5):403-9.

27. Vafaie M., Slagman A., Mockel M. et al. Prognostic value of undetectable hs troponin T in suspected acute coronary syndrome. Am J Med 2016;129(3):274-82.

28. Shah A.S., Anand A., Sandoval Y. et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 2015;386:2481-8.

29. Reichlin T., Cullen L., Parsonage W.A. et al. Two-hour-algorithm for triage toward rule-out and rulein of acute myocardial infarction using high-sensitivity cardiac troponin T. Am J Med 2015;128(4):369-79.

30. Schreiber D.H., Agbo C., Wu A.H.B. et al. Short-term (90 min) diagnostic performance for acute nonST segment elevation myocardial infarction and 30-day prognostic evaluation of a novel third-generation high sensitivity troponin I assay. Clin Biochem 2012;45(16-17):1295-301.

31. Reichlin T., Twerenbold R., Wildi K. et al. Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. CMA J 2015;187:243-52.

32. Druey S., Wildi K., Twerenbold R. et al. Early rule-out and rule-in of myocardial infarction using sensitive cardiac troponin I. Int J Cardiol 2015;195:163-70.

33. Jobs A., Thiele ESC guidelines 2015: Non-ST elevation acute coronary syndrome. Herz 2015;40(8):1027-33.

34. Eggers K.M. Conseqences of the implementation of a high-sensitivity cardiac troponin assay at Swedish coronary care units. Presented at: European Society of Cardiology Congress; September 1, 2015; London, England.

For citation:

Kremneva L.V., Suplotov S.N., Shalaev S.V. ESTIMATION OF HIGHLY SENSITIVE TROPONIN TESTS IN THE DIAGNOSIS OF ACUTE CORONARY SYNDROME. Rational Pharmacotherapy in Cardiology. 2016;12(2):204-209. (In Russ.)

Views: 650

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)